Percent who seroconverted (anti-rota serum IgA, 2 months post dose 2) [clinicaltrials_resource:ab7f5014052ab574d45629df9aa893e0]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Percent who seroconverted (anti-rota serum IgA, 2 months post dose 2) [clinicaltrials_resource:ab7f5014052ab574d45629df9aa893e0]
Bio2RDF identifier
ab7f5014052ab574d45629df9aa893e0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ab7f5014052ab574d45629df9aa893e0
measure [clinicaltrials_vocabulary:measure]
Percent who seroconverted (anti-rota serum IgA, 2 months post dose 2)
identifier
clinicaltrials_resource:ab7f5014052ab574d45629df9aa893e0
title
Percent who seroconverted (anti-rota serum IgA, 2 months post dose 2)
@en
type
label
Percent who seroconverted (ant ...... f5014052ab574d45629df9aa893e0]
@en